Expression and clinical significance of CD44 and nm23-H1 proteins in non-small cell lung cancer
LI Xue-man1,2, YANG Gui-fang1
(1.Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan Hubei 430030；2.Department of Thoracic Surgey, the Third Hospital of Wuhan, Wuhan Hubei 430060, China)
Abstract：Objective: To study the expressions of CD44 and nm23-H1 proteins and their clinical significance in nonsmall cell lung cancer. Methods: Immunohistochemical technique was used to examine the expressions of CD44 and nm23-H1 proteins in 42 nonsmall cell lung cancer, 21 surrounding normal lung tissues and 12 tissues of benign lung disease. Results：The expressions of CD44 proteins in nonsmall cell lung cancer were much higher than that in benign lung disease and the expressions of the nm23H1 were markedly lower in the same cases(both P＜0.01). The expressions of CD44 proteins in lung cancer tissues with metastatic lymph node was significantly higher than that in lung cancer without metastatic lymph node(χ2=4.921, P=0.027), but nm23-H1 protein expression was lower(χ2=4.805, P=0.028)．Therefore, the expression of CD44 protein was positively correlated with the metastasis，clinical staging．While the expression of nm23H1protein was negatively correlated with lymph node metastasis and clinical staging of lung cancer. Neither was correlated with tumor differential degree. Conclusions：CD44 and nm23-H1 gene proteins might play an important coordinated regular role in the carcinogenesis，development and metastasis of lung cancer and would be the key biological marks in judging and evaluating the prognosis of non-small cell lung cancer．
收稿日期: 2012-12-16
作者简介: 李雪曼(1982—)，女，湖北武汉人，主治医师，主要从事肺部恶性肿瘤病理研究。
引用本文:
李雪曼1,2, 杨桂芳1. 非小细胞肺癌中CD44和nm23-H1的表达及临床意义[J]. 江苏大学学报:医学版, 2013, 23(1): 39-41,45.
LI Xue-man1,2, YANG Gui-fang1. Expression and clinical significance of CD44 and nm23-H1 proteins in non-small cell lung cancer. Journal of Jiangsu University(Medicine Edition), 2013, 23(1): 39-41,45.
［1］龚道军，谢志徽.肝细胞癌组织中MMP-9，CD44V6与nm23-H1表达的相关性及意义［J］.肝胆胰外科杂志，2006,18(6):352-354. [ 2] 徐艳萍，金春顺，孙立群，等. nm23-H1等位基因缺失与喉癌转移相关性研究［J］.中国老年学杂志， 2009，29(18):2296-2297.［3］赵京，孙玉鄂，张连斌．CD44的表达与人类非小细胞肺癌淋巴转移相关性的初步研究［J］．中国肺癌杂志，2000，3(2):115-117.［4］Lopez JI, Camenisch TD, Stevens MV, et al. CD44 attenuates metastatic invasion during breast cancer progression［J］.Cancer Res, 2005, 65(15):6755-6763.［5］黄兰卿，梁红卫，容永璋，等．肺癌患者血清中sCD44V6含量及内镜活检组织中CD44V6表达的临床意义［J］．中华实验外科杂志，2005，22(10)1231-1232．［6］梁传余，刘春青．CD44基因表达与喉癌生物学行为的关系［J］．四川医学，2003，24(12)：1222-1223．［7］Liotta LA，Steeg PS. Clues to the function of Nm23 and Awd proteins in development, signal transduction, and tumor metastasis provided by studies of Dictyostelium discoideum［J］. J Natl Cancer Inst, 1990, 82(14):1170-1172.［8］周清华. 肺癌基础研究与临床治疗进展［M］.北京：科学出版社，1999:8-9.［9］张贤芬，赵书佑，张丽君．转移抑制基因nm23-H1在喉癌、下咽癌及其转移淋巴结中的表达［J］．山东大学基础医学院学报，2003，17(5)：282-284．
2013, Vol. 23 
